comprehensive -WSS

comprehensive

author：leisure time 2025-10-04 11:42:51 - browse：8748

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： FDA approves Sage Therapeutics’ rapid

WSS

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Medicare innovation center doesn’t save money, experts say

CDC recommends RSV monoclonal antibody for infants

Setback for rare diseases as Taysha Gene Therapies pulls back

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Wikipedia

comprehensive

hotspot

How one medical school became remarkably diverse

The United States is paying nearly triple for new Covid vaccines

Jerome Adams on the need for new antivirals for Covid

What we owe ALS patients — and why one company fell short

Alkermes shareholders re

Alnylam reports growth in sales of rare disease treatments

How to save PrEP access — and even expand it

Florida officials tell state schools to teach AP Psychology 'in its entirety'

United colonoscopy coverage change 'may cost lives,' doctors say

Pharma showers House GOP doctor with campaign cash

focus

The United States is paying nearly triple for new Covid vaccines

H.R. 3 is the wrong path to lower drug costs

It costs an awful lot of money to give away a kidney

IVG is promising — but it won’t replace IVF quite yet

CRISPR base editing slashes cholesterol levels in monkeys

IVG is promising — but it won’t replace IVF quite yet

hotspot

Wikipedia

knowledge

hotspot